In colon cancer cells, the knockdown of proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces both macrophage migration inhibitory factor (MIF) expression and lactylation levels, thereby promoting macrophage M1-type polarization (105). Here, PCSK9 is linked to colonic neoplasm.